Sandra van der Poel – Smet, is working for a CRO named Xendo (formally Vigilex) and appointed as contracted EEA QPPV on behalf of different global clients. Sandra has over 25 years of work experience in different pharmaceutical companies, initially she started in clinical development and since 1997 focusses on pharmacovigilance (PV). Next to PV she has experience with project management (Prince2) and Six Sigma (green belt), which supports effective and sufficient process development.